Monoclonal gammapathies
PDF (Français (France))

Keywords

Monoclonal immunoglobulin
multiple myeloma
monoclonal gammapathy of undetermined significance
Waldenstrom’s macroglobulinemia
amylosis

Categories

How to Cite

Bouatay, A., Braham-Jemili, N., Hassine, M., & Kortas, M. (2015). Monoclonal gammapathies. Revue Tunisienne De BIOLOGIE CLINIQUE, 22(1). https://doi.org/10.71699/revtunbiolclin.v22i1.81

Abstract

A monoclonal gammapathy is characterized by a selective increase of a single serum immunoglobulin due to an only dysregulated clone of B lymphocytes. The laboratory diagnosis of monoclonal immunoglobulins needs a linked serum and urine analysis showing charge and isotype homogeneity. Monoclonal gammapathies are common in the general population and affect about 3% in general population older than age 50. They are a very heterogeneous group of diseases of different etiologies. At presentation about half of them are classified as MGUS (monoclonal gammopathy of undetermined significance) whereas only 30 % have clinically documented plasma cell dyscrasias (multiple myeloma (MM), Waldenstrom’s macroglobulinemia (WM), primary systemic amyloidosis (AL), or a related disorder. Multiple myeloma (MM) is comprised about of 80% monoclonal gammopathies. It is characterized by plasma cells proliferation (>10%) within the bone marrow and an excess of secreted monoclonal immunoglobulins.

https://doi.org/10.71699/revtunbiolclin.v22i1.81
PDF (Français (France))
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2015 Revue Tunisienne de BIOLOGIE CLINIQUE

Downloads

Download data is not yet available.